Sources and updates, October 1
Sources and updates for the week of October 1 include new Long COVID data, mutation risk from an antiviral drug, accessibility issues for COVID-19 websites, and more.
Read MoreSources and updates for the week of October 1 include new Long COVID data, mutation risk from an antiviral drug, accessibility issues for COVID-19 websites, and more.
Read MoreSources and updates for the week of July 31 include slow vaccine uptake for young kids, next-generation vaccines, COVID-19’s origins, and more.
Read MoreSources and updates for the week of March 6 include COVID-19 relief funding in schools, Long COVID estimates, and more.
Read MoreIt’s been about a month since the FDA and CDC authorized a version of Pfizer’s vaccine for children ages five to 11. Those kids whose parents immediately took them to get vaccinated are now eligible for their second doses, and will be considered fully vaccinated by Christmas. Despite widespread availability of the shots, vaccine uptake has varied wildly.
Read MoreWhile politicians at all levels have praised cash incentives, research has shown that this strategy has little impact on actually convincing Americans to get vaccinated. A recent investigation I worked on (at the Documenting COVID-19 project and the Missouri Independent) provides new evidence for this trend: the state of Missouri allocated $11 million for gift cards that residents could get upon receiving their first or second vaccine dose, but the vast majority of local health departments opted not to participate in the program—and a very small number of gift cards have been distributed thus far.
Read MoreLast week, the Food and Drug Administration (FDA) recommended Pfizer’s COVID-19 vaccine for children ages 5 to 11, under an Emergency Use Authorization. The agency’s vaccine advisory committee met on Tuesday to discuss Pfizer’s application and voted overwhelmingly in favor; the FDA followed this up with an EUA announcement on Friday.
Read MoreFeatured sources for the week of September 19 include K-12 testing, vaccine hesitancy, hospital reporting, and Long COVID.
Read MoreFeatured sources for July 18 include coronavirus variants, long COVID, excess deaths, vaccine hesitancy, and more.
Read MoreFeatured sources for the week of June 27 include vaccine hesitancy, nursing homes, and housing.
Read MoreThe problem child of COVID-19 vaccines was back in the news this week. After South Africa suspended the Oxford-AstraZeneca vaccine’s use when it failed to slow the spread of the predominant B.1.351 variant, vaccination using this vaccine has been suspended and then resumed in many European countries following reports of blood clots in some people who received it.
Read More